Visit Sclero Forums, Chats and Blogs!
 
Search sclero.org:
 
The most important thing in the world to know about
scleroderma is sclero.org with 5,000+ pages in 23 languages!
 
Donate in MemoryIn loving memory of Tom Regensburger, and Vera Kortan . (Donate)
Home   Medical   News   *Sclero Forums*   Support   Languages/Countries
Earn $150 on July 30th in Boston Marketing Research Study if you have scleroderma or CTD and have been screened for pulmonary hypertension!
Frog jumping for joy by Shelley EnszPDF Flyer: Boston Marketing Research Study. Schlesinger Associates-Boston, a national marketing research company, is currently looking for patients who have been diagnosed with Scleroderma or other Connective Tissue Disease, who either have pulmonary hypertension or who are regularly screened for it, to participate in a July 30th paid marketing research study in Boston. Read PDF Flyer: Boston Marketing Research Study or call Katherine at 617-542-5500 x310. Schlesinger Associates-Boston. Posted 07/26/10.
Scleroderma Newsroom
Janey WillisHello, I am Janey Willis, ISN News Director and ISN Asst. Webmaster. David Becker, ISN Assistant News Guide researches our Autoimmune News section. Jeannie McClelland, ISN Assistant News Guide, researches Scleroderma Medical and Media News. Assistant News Guide Lisa Bulman posts these stories to our Sclero Forums.
Scleroderma Medical News
Autoimmune News
Media Stories
New Personal Stories
ISN Website & Donation News

Autoimmune Medical News by Date

January 2010
Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome (APS). Women with thrombotic APS have higher rates of pregnancy complications than those with obstetric APS. (SageJournals) K. Bramham. Lupus, Vol. 19, No. 1, 58-64 (2010). (Also see: Complications of APS)
Sarcoidosis in World Trade Center Rescue Workers Presenting With Rheumatologic Manifestations. We describe 2 cases of sarcoidosis in rescue workers with significant exposure from the World Trade Center collapse, who presented with extrapulmonary rheumatologic manifestations. B. Bowers, D.O. Journal of Clinical Rheumatology. January 2010.Volume 16. Issue 1. pp 26-27. (Also see: Causes of Sarcoidosis)
Development of sarcoidosis following etanercept treatment: a report of three cases. We present three patients who developed sarcoidosis while on etanercept treatment, and discuss if possible differences in cytokine profiles and T regulatory cell function in patients taking different TNF-α inhibitors may explain this paradox. (SpringerLink) I.M. Skoie. Rheumatology International. January 9 2010. (Also see: Causes of Sarcoidosis and Etanercept)
Primary Raynaud phenomenon and small-fiber neuropathy (SFN): is there a connection? A pilot neurophysiologic study. The presence of SFN raises the possibility that a subset of patients with primary RP have an underlying, subclinical small-fiber dysfunction. (SpringerLink) N. Manek. Rheumatology International. December 24 2009. (Also see: Raynaud’s)
Systemic Amyloidosis Presenting as Chronic Diarrhea in a Patient With Ankylosing Spondylitis. We report a case of systemic amyloidosis that presented primarily as chronic diarrhea in a patient with ankylosing spondylitis. Consideration of amyloidosis as a diagnosis in patients who have chronic uncontrolled inflammatory conditions is also important in preventing poor outcomes related to this disease. ZH McMahan, MD. Journal of Clinical Rheumatology. January 2010. (Also see: Ankylosing Spondylitis)
Vitamin D insufficiency in a large female SLE cohort. Sub-optimal vitamin D status is common in women with systemic lupus erythematosus and is related to season, cumulative glucocorticoid dose, and serum creatinine. (SageJournals) SMA Toloza. January 1 2010. (Also see: Research About Lupus)
Pregabalin in fibromyalgia (FM): meta-analysis of efficacy and safety from company clinical trial reports. Pregabalin is effective in treating FM and is relatively safe. S. Straube. Rheumatology Advance Access. January 7 2010. (Also see: Treatments for FM)
Pancreatitis in Systemic Lupus Erythematosus (SLE): Frequency and Associated Factors - A Review of the Hopkins Lupus Cohort. Hypertriglyceridemia appears to be a strong associate of pancreatitis in SLE, but antiphospholipid antibodies are not. SLE patients with psychosis and pleurisy are at increased risk for pancreatitis. A. Mikol. JRheum. December 23 2009. (Also see: Lupus and Overlapping Diseases)
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. In addition to age, positive antiphospholipid antibody, biomarkers indicating increased endothelial cell activity/damage, and absence of thrombocytopenia were independent predictors of CVEs in this prospective study. J. Gustafsson. Arthritis Research & Therapy. December 10 2009. (Also see: Symptoms of Lupus)
Dermatomyositis (DM): current and future treatments. This article will highlight therapeutic options used for cutaneous disease in DM, while also describing therapies for both muscle and systemic disease. therapeutic selection should be made only after careful consideration of a patient’s comorbidities, disease severity, presence of systemic involvement and search for a potentially associated malignancy. (ExpertReviews) R.A. Vleugels. Expert Review of Dermatology. December 2009. (Also see: Dermatomyositis)
Nicotine-patch therapy on mucocutaneous lesions of Behçet’s disease (BD): a case series. At least in ex-smokers, nicotine in its pure form is well tolerated and its use could be justified in selected cases of BD with predominant and recurrent refractory mucocutaneous manifestations. G. Siancio. Rheumatology Advance Access. December 16 2009. (Also see: Behcet's)
An unusual case of undifferentiated connective tissue disease (UCTD) presenting as cardiac tamponade. This case presents UCTD as a rare cause of cardiac tamponade and large pericardial effusions and suggests that colchicine can be used to treat UCTD-associated effusions. (SpringerLink) P. Hari. Rheumatology International. December 16 2009. (Also see: UCTD and Cardiac Complications)
 
Go to Autoimmune News: Decemeber 2009
 
SCLERO.ORG is brought to you by the nonprofit International Scleroderma Network (ISN). The ISN is a full-service nonprofit scleroderma charitable foundation providing stellar research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension.
  1. Post a message in Sclero Forums
  2. Email: isn@sclero.org
  3. English Email Form
  4. Español Email Form
  5. Italiano Email Form
International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702
United States

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information: verify here.

Toll Free Hotline in U.S.
Hours: 9am-3pm CST only.
Please leave a complete message, in English.
1-800-564-7099
Direct Line
1-952-583-5735
We are also known as the Scleroderma from A to Z web site.
Privacy Policy, Financial Disclosure, and Disclaimer.
© Copyright 1998-2010 International Scleroderma Network
All Rights Reserved
 
Home   Donate   Medical   News   *Sclero Forums*   Support   Translations   Search